Pathway Genomics Stock

pathway.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $127.23MM

Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Pathway Genomics before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like Pathway Genomics before its M&A.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Pathway Genomics’ stock FAQs


Can you buy Pathway Genomics’ stock?

You can no longer buy Pathway Genomics’ stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Can you sell Pathway Genomics’ stock?

You can no longer sell stock of Pathway Genomics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Pathway Genomics investors also invested in these private companies

International Business Machines


Management Team

Kamal Adawi
K'Lene Oen
Chief Business Officer
Nilesh Dharajiya MD
Chief Laboratory Officer & Medical Director
James Plante
Founder, Board Member, CEO
Glenn Braunstein MD
Chief Medical Officer
Anja Kammesheidt Ph.D
Chief Scientific Officer
Michael Nova Ph.D
Chief Innovation Officer

Board Members

Christopher Kitching
Mark Sopp
Pathway Genomics
Peter Leddy Ph.D
Peter Pace


Prostate Biopsy Market Size, Application,Revenue, Types, Trends in Future, Scope to 2021 - TokensJournal

The Prostate Biopsy Market  report  provides valuable and unique information which is very  essential. Further it also covers key players,application and future market condition.This information is extremely useful information for new and growing  company to mark themself over the market Prostate Biopsy market to grow at a CAGR OF 12.66% during the period 2017-2021. This …

Direct-To-Consumer Genetic Testing Market with top 20 Countries data Forecast to 2022 with Global Key Companies Profile, Supply, Demand, Cost Structure and Growth Factors - TokensJournal

Direct-To-Consumer Genetic Testing Market Report cover detailed competitive outlook including the Direct-To-Consumer Genetic Testing Industry share and company profiles of the key participants operating in the global market. The Direct-To-Consumer Genetic Testing market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and …

Direct-to-consumer Genetic Testing Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2023 - BitsEther

Direct-to-consumer Genetic Testing Market Research highlights key dynamics of Global Direct-to-consumer Genetic Testing Industry sector. The potential of the Direct-to-consumer Genetic Testing Market has been investigated along with the key challenges. The current Direct-to-consumer Genetic Testing Market scenario and future prospects of the sector has also been studied. Market Report provides additional information like Sales Channel, Distributors, Traders …
Updated on: Jul 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.